Archives of Craniofacial Surgery (대한두개안면성형외과학회지)

Korean Cleft Palate-Craniofacial Association (대한두개안면성형외과학회)
권호 표지
DOI QR코드

DOI QR Code

Current concepts of craniofacial fibrous dysplasia: pathophysiology and treatment

  • Dong Yeon Kim (Department of Plastic and Reconstructive Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea)
  • Received : 2023.03.06
  • Accepted : 2023.04.10
  • Published : 2023.04.20
Download PDF
⟨ Previous Next ⟩

Abstract

Fibrous dysplasia is an uncommon genetic disorder in which bone is replaced by immature bone and fibrous tissue, manifesting as slow-growing lesions. Sporadic post-zygotic activating mutations in GNAS gene result in dysregulated GαS-protein signaling and elevation of cyclic adenosine monophosphate in affected tissues. This condition has a broad clinical spectrum, ranging from insignificant solitary lesions to severe disease. The craniofacial area is the most common site of fibrous dysplasia, and nine out of 10 patients with fibrous dysplasia affecting the craniofacial bones present before the age of 5. Surgery is the mainstay of treatment, but the technique varies according to the location and severity of the lesion and associated symptoms. The timing and indications of surgery should be carefully chosen with multidisciplinary consultations and a patient-specific approach.

Keywords

References

  1. St. Clair EG, McCutcheon IE. Skull tumors. In: Winn H, editor. Youmans and Winn neurological surgery. Elsevier; 2022. p. 1444. e1-e26. 
  2. Yang L, Wu H, Lu J, Teng L. Prevalence of different forms and involved bones of craniofacial fibrous dysplasia. J Craniofac Surg 2017;28:21-5.  https://doi.org/10.1097/SCS.0000000000002830
  3. Rahman AM, Madge SN, Billing K, Anderson PJ, Leibovitch I, Selva D, et al. Craniofacial fibrous dysplasia: clinical characteristics and long-term outcomes. Eye (Lond) 2009;23:2175-81.  https://doi.org/10.1038/eye.2009.6
  4. Ricalde P, Magliocca KR, Lee JS. Craniofacial fibrous dysplasia. Oral Maxillofac Surg Clin North Am 2012;24:427-41.  https://doi.org/10.1016/j.coms.2012.05.004
  5. Ippolito E, Bray EW, Corsi A, De Maio F, Exner UG, Robey PG, et al. Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J Pediatr Orthop B 2003;12:155-77.  https://doi.org/10.1097/01202412-200305000-00001
  6. Byers PD, Jones AN. Leontiasis ossea. Br J Surg 1969;56:262-7.  https://doi.org/10.1002/bjs.1800560406
  7. Chapurlat RD, Orcel P. Fibrous dysplasia of bone and McCune-Albright syndrome. Best Pract Res Clin Rheumatol 2008;22:55-69.  https://doi.org/10.1016/j.berh.2007.11.004
  8. Weinstein LS. G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome. J Bone Miner Res 2006;21 Suppl 2:P120-4.  https://doi.org/10.1359/jbmr.06s223
  9. Lumbroso S, Paris F, Sultan C. McCune-Albright syndrome: molecular genetics. J Pediatr Endocrinol Metab 2002;15 Suppl 3:875-82. 
  10. Weinstein LS, Yu S, Warner DR, Liu J. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev 2001;22:675-705.  https://doi.org/10.1210/edrv.22.5.0439
  11. Happle R. The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet 1986;29:321-4.  https://doi.org/10.1111/j.1399-0004.1986.tb01261.x
  12. Ricalde P, Horswell BB. Craniofacial fibrous dysplasia of the fronto-orbital region: a case series and literature review. J Oral Maxillofac Surg 2001;59:157-68.  https://doi.org/10.1053/joms.2001.20487
  13. Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 2003;112:683-92.  https://doi.org/10.1172/JCI18399
  14. Riminucci M, Kuznetsov SA, Cherman N, Corsi A, Bianco P, Gehron Robey P. Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone 2003;33:434-42.  https://doi.org/10.1016/S8756-3282(03)00064-4
  15. Riminucci M, Fisher LW, Shenker A, Spiegel AM, Bianco P, Gehron Robey P. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 1997;151:1587-600. 
  16. Collins MT, Chebli C, Jones J, Kushner H, Consugar M, Rinaldo P, et al. Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 2001;16:806-13.  https://doi.org/10.1359/jbmr.2001.16.5.806
  17. Hart ES, Kelly MH, Brillante B, Chen CC, Ziran N, Lee JS, et al. Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res 2007;22:1468-74.  https://doi.org/10.1359/jbmr.070511
  18. Robey PG, Kuznetsov S, Riminucci M, Bianco P. The role of stem cells in fibrous dysplasia of bone and the Mccune-Albright syndrome. Pediatr Endocrinol Rev 2007;4 Suppl 4:386-94. 
  19. Burke AB, Collins MT, Boyce AM. Fibrous dysplasia of bone: craniofacial and dental implications. Oral Dis 2017;23:697-708.  https://doi.org/10.1111/odi.12563
  20. Bousson V, Rey-Jouvin C, Laredo JD, Le Merrer M, Martin-Duverneuil N, Feydy A, et al. Fibrous dysplasia and McCune-Albright syndrome: imaging for positive and differential diagnoses, prognosis, and follow-up guidelines. Eur J Radiol 2014;83:1828-42.  https://doi.org/10.1016/j.ejrad.2014.06.012
  21. Javaid MK, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A, et al. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium. Orphanet J Rare Dis 2019;14:139. 
  22. Lee JS, FitzGibbon E, Butman JA, Dufresne CR, Kushner H, Wientroub S, et al. Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med 2002;347:1670-6.  https://doi.org/10.1056/NEJMoa020742
  23. Collins MT, Singer FR, Eugster E. McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia. Orphanet J Rare Dis 2012;7(Suppl 1):S4. 
  24. Chanson P, Salenave S, Orcel P. McCune-Albright syndrome in adulthood. Pediatr Endocrinol Rev 2007;4 Suppl 4:453-62. 
  25. Boyce AM, Brewer C, DeKlotz TR, Zalewski CK, King KA, Collins MT, et al. Association of hearing loss and otologic outcomes with fibrous dysplasia. JAMA Otolaryngol Head Neck Surg 2018;144:102-7.  https://doi.org/10.1001/jamaoto.2017.2407
  26. Yabut SM Jr, Kenan S, Sissons HA, Lewis MM. Malignant transformation of fibrous dysplasia: a case report and review of the literature. Clin Orthop Relat Res 1988;(228):281-9. 
  27. Ozcan I, Unsal G, Koca RB, Orhan K. Craniofacial fibrous dysplasia involvements of Mccune-Albright syndrome: a review with an additional case. Curr Med Imaging 2021;17:864-70.  https://doi.org/10.2174/1573405616666201209102418
  28. Paul SM, Gabor LR, Rudzinski S, Giovanni D, Boyce AM, Kelly MR, et al. Disease severity and functional factors associated with walking performance in polyostotic fibrous dysplasia. Bone 2014;60:41-7.  https://doi.org/10.1016/j.bone.2013.11.022
  29. DiCaprio MR, Enneking WF. Fibrous dysplasia: pathophysiology, evaluation, and treatment. J Bone Joint Surg Am 2005;87:1848-64.  https://doi.org/10.2106/00004623-200508000-00028
  30. Boyce AM, Kelly MH, Brillante BA, Kushner H, Wientroub S, Riminucci M, et al. A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone. J Clin Endocrinol Metab 2014;99:4133-40.  https://doi.org/10.1210/jc.2014-1371
  31. Chapurlat RD, Delmas PD, Liens D, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 1997;12:1746-52.  https://doi.org/10.1359/jbmr.1997.12.10.1746
  32. Liens D, Delmas PD, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 1994;343:953-4.  https://doi.org/10.1016/S0140-6736(94)90069-8
  33. Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH. Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab 2003;88:4569-75.  https://doi.org/10.1210/jc.2003-030050
  34. Metwally T, Burke A, Tsai JY, Collins MT, Boyce AM. Fibrous dysplasia and medication-related osteonecrosis of the jaw. J Oral Maxillofac Surg 2016;74:1983-99.  https://doi.org/10.1016/j.joms.2016.04.001
  35. Chapurlat RD. Medical therapy in adults with fibrous dysplasia of bone. J Bone Miner Res 2006;21 Suppl 2:P114-9.  https://doi.org/10.1359/jbmr.06s222
  36. Rotman M, Hamdy NA, Appelman-Dijkstra NM. Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone. Br J Clin Pharmacol 2019;85:1169-79.  https://doi.org/10.1111/bcp.13820
  37. Lisle DA, Monsour PA, Maskiell CD. Imaging of craniofacial fibrous dysplasia. J Med Imaging Radiat Oncol 2008;52:325-32.  https://doi.org/10.1111/j.1440-1673.2008.01963.x
  38. Choi JH, Baek W. Late reconstruction of post-traumatic enophthalmos and hypoglobus using three-dimensional implants: a case series. Arch Craniofac Surg 2022;23:232-6.  https://doi.org/10.7181/acfs.2022.00850
  39. Choi JH, Roh TS, Lee WJ, Baek W. Cranioplasty and temporal hollowing correction with a three-dimensional printed bioresorbable mesh and double vertical suture anchor muscle sling: a case report. Arch Craniofac Surg 2022;23:178-82.  https://doi.org/10.7181/acfs.2022.00682
  40. Becelli R, Perugini M, Cerulli G, Carboni A, Renzi G. Surgical treatment of fibrous dysplasia of the cranio-maxillo-facial area: review of the literature and personal experience form 1984 to 1999. Minerva Stomatol 2002;51:293-300. 
  41. Hartley I, Zhadina M, Collins MT, Boyce AM. Fibrous dysplasia of bone and McCune-Albright syndrome: a bench to bedside review. Calcif Tissue Int 2019;104:517-29.  https://doi.org/10.1007/s00223-019-00550-z
  42. Sachs SA. Two case studies of fibrous dysplasia encompassing three decades: a clinical pathologic review. Oral Maxillofac Surg Clin North Am 1997;9:731-49.  https://doi.org/10.1016/S1042-3699(20)30966-3
  43. Boyce AM, Burke A, Cutler Peck C, DuFresne CR, Lee JS, Collins MT. Surgical management of polyostotic craniofacial fibrous dysplasia: long-term outcomes and predictors for postoperative regrowth. Plast Reconstr Surg 2016;137:1833-9.  https://doi.org/10.1097/PRS.0000000000002151
  44. Kang SJ, Oh MJ, Jeon SP. A novel and easy approach for contouring surgery in patients with craniofacial fibrous dysplasia. J Craniofac Surg 2015;26:1977-8.  https://doi.org/10.1097/SCS.0000000000001953
  45. Boyce AM, Glover M, Kelly MH, Brillante BA, Butman JA, Fitzgibbon EJ, et al. Optic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone excess. J Clin Endocrinol Metab 2013;98:E126-34.  https://doi.org/10.1210/jc.2012-2111
  46. Tessaris D, Boyce AM, Zacharin M, Matarazzo P, Lala R, De Sanctis L, et al. Growth hormone-insulin-like growth factor 1 axis hyperactivity on bone fibrous dysplasia in McCune-Albright Syndrome. Clin Endocrinol (Oxf) 2018;89:56-64.  https://doi.org/10.1111/cen.13722
  47. Chen YR, Noordhoff MS. Treatment of craniomaxillofacial fibrous dysplasia: how early and how extensive? Plast Reconstr Surg 1990;86:835-44.  https://doi.org/10.1097/00006534-199011000-00002
  48. Ahn SJ, Hong JW, Kim YO, Lew DH, Lee WJ. Treatment of fibrous dysplasia of the zygomaticomaxillary complex with radical resection and three-dimensional reconstruction with autologous calvarial bone graft. Arch Craniofac Surg 2018;19:200-4.  https://doi.org/10.7181/acfs.2018.00052
  49. Seo BF, Kang KJ, Jung SN, Byeon JH. Skeletal cavernous hemangiomas of the frontal bone with orbital roof and rim involvement. Arch Craniofac Surg 2018;19:214-7.  https://doi.org/10.7181/acfs.2018.01921
  50. Cho SW, Choi WS, Kim BK. A multimodal approach to huge fibrous dysplasia with ocular symptoms using a navigation system and endoscope. J Craniofac Surg 2022;33:e342-5.  https://doi.org/10.1097/SCS.0000000000008255
  51. Choi JW, Lee SW, Koh KS. Correction of proptosis and zygomaticomaxillary asymmetry using orbital wall decompression and zygoma reduction in craniofacial fibrous dysplasia. J Craniofac Surg 2009;20:326-30.  https://doi.org/10.1097/SCS.0b013e31819922d3
  52. Lee YH, Hwang K. Decortication of fibrous dysplasia of the maxillary sinus. J Craniofac Surg 2011;22:139-41.  https://doi.org/10.1097/SCS.0b013e3181f7390a
  53. Kim JH, Kim J, Cho SW, Kim BK. Core extirpation and zygoma reduction: a new surgical approach for fibrous dysplasia of zygomaticomaxillary region. J Craniofac Surg 2022;33:1174-7.  https://doi.org/10.1097/SCS.0000000000007961
  54. Chattopadhyay A, Jain S, Sharma A. Craniofacial fibrous dysplasia. J Clin Rheumatol 2020;26:e214. 
  55. Hu AC, Lee CJ, Hsu FP, Vyas RM. Extensive polyostotic craniofacial fibrous dysplasia with optic nerve impingement. J Craniofac Surg 2021;32:e435-7.  https://doi.org/10.1097/SCS.0000000000007241
  56. Kim HS, Kim WS, Kim HK, Bae TH. Removal of intraosseous hemangioma in frontal bone under direct vision through a small incision. Arch Craniofac Surg 2021;22:52-5.  https://doi.org/10.7181/acfs.2020.00661
  57. Papadopoulos MC, Casey AT, Powell M. Craniofacial fibrous dysplasia complicated by acute, reversible visual loss: report of two cases. Br J Neurosurg 1998;12:159-61.  https://doi.org/10.1080/02688699845320
  58. Cutler CM, Lee JS, Butman JA, FitzGibbon EJ, Kelly MH, Brillante BA, et al. Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation. Neurosurgery 2006;59:1011-8.  https://doi.org/10.1227/01.NEU.0000254440.02736.E3
  59. Seo HJ, Choi YK. Current trends in orthognathic surgery. Arch Craniofac Surg 2021;22:287-95.  https://doi.org/10.7181/acfs.2021.00598
  60. Yeow VK, Chen YR. Orthognathic surgery in craniomaxillofacial fibrous dysplasia. J Craniofac Surg 1999;10:155-9.  https://doi.org/10.1097/00001665-199903000-00012
  61. Cheung LK, Samman N, Pang M, Tideman H. Titanium miniplate fixation for osteotomies in facial fibrous dysplasia: a histologic study of the screw/bone interface. Int J Oral Maxillofac Surg 1995;24:401-5.  https://doi.org/10.1016/S0901-5027(05)80467-9
  62. Meiselman F. Fibrous dysplasia of the facial bones: combined recontouring and orthognathic surgical treatment. Oral Maxillofac Surg Clin North Am 1997;9:721-9. https://doi.org/10.1016/S1042-3699(20)30965-1